Caricamento...
The Role of Finerenone in the Management of Diabetic Nephropathy
Diabetic nephropathy (DN) is the leading cause of chronic kidney disease. Even though mineralocorticoid receptor antagonists (MRA) induce incremental reductions in urine albumin excretion when added to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, this combination is inf...
Salvato in:
| Pubblicato in: | Diabetes Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Healthcare
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8266950/ https://ncbi.nlm.nih.gov/pubmed/34050896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01085-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|